3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Sarcoma
2
Gynecologic
2
CNS
2
Thoracic
1
Other neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Neuroendocrine Tumors
110
Gastro-enteropancreatic neuroendocrine tumor
19
Carcinoma, Neuroendocrine
12
Stomach Neoplasms
10
Neoplasms
10
Breast Neoplasms
10
Pheochromocytoma
9
Pancreatic Neoplasms
9
Carcinoid Tumor
9
Prostatic Neoplasms
8
Paraganglioma
8
Neoplasm Metastasis
8
Carcinoma, Hepatocellular
8
Adenoma, Islet Cell
8
Thyroid Neoplasms
7
Gastrointestinal Neoplasms
7
Esophageal Neoplasms
7
Sarcoma
6
Lung Neoplasms
6
Colorectal Neoplasms
6
Rectal Neoplasms
5
Ovarian Neoplasms
5
Neuroblastoma
5
Melanoma
5
Liver Neoplasms
5
Colonic Neoplasms
5
Anus Neoplasms
5
Uterine Cervical Neoplasms
4
Gastrointestinal Stromal Tumors
4
Cholangiocarcinoma
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Glandular and Epithelial
×
NET
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled